These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

559 related items for PubMed ID: 17355738

  • 21. Neurocognition and its influencing factors in the treatment of schizophrenia-effects of aripiprazole, olanzapine, quetiapine and risperidone.
    Riedel M, Schennach-Wolff R, Musil R, Dehning S, Cerovecki A, Opgen-Rhein M, Matz J, Seemüller F, Obermeier M, Engel RR, Müller N, Möller HJ, Spellmann I.
    Hum Psychopharmacol; 2010 Mar; 25(2):116-25. PubMed ID: 20196179
    [Abstract] [Full Text] [Related]

  • 22. Relationship between psychopathology and cognitive functioning in schizophrenia.
    Bozikas VP, Kosmidis MH, Kioperlidou K, Karavatos A.
    Compr Psychiatry; 2004 Mar; 45(5):392-400. PubMed ID: 15332203
    [Abstract] [Full Text] [Related]

  • 23. Add-on mirtazapine enhances effects on cognition in schizophrenic patients under stabilized treatment with clozapine.
    Delle Chiaie R, Salviati M, Fiorentini S, Biondi M.
    Exp Clin Psychopharmacol; 2007 Dec; 15(6):563-8. PubMed ID: 18179309
    [Abstract] [Full Text] [Related]

  • 24. Transdermal rivastigmine treatment does not worsen impaired performance of complex motions in patients with Alzheimer's disease.
    Muhlack S, Przuntek H, Müller T.
    Pharmacopsychiatry; 2006 Jan; 39(1):16-9. PubMed ID: 16453249
    [Abstract] [Full Text] [Related]

  • 25. Spatial working memory and problem solving in schizophrenia: the effect of symptom stabilization with atypical antipsychotic medication.
    Snyder PJ, Jackson CE, Piskulic D, Olver J, Norman T, Maruff P.
    Psychiatry Res; 2008 Sep 30; 160(3):316-26. PubMed ID: 18579217
    [Abstract] [Full Text] [Related]

  • 26. [Learning potential and cognitive remediation in schizophrenia].
    Raffard S, Gely-Nargeot MC, Capdevielle D, Bayard S, Boulenger JP.
    Encephale; 2009 Sep 30; 35(4):353-60. PubMed ID: 19748372
    [Abstract] [Full Text] [Related]

  • 27. The effect of risperidone on cognitive functioning in a sample of Asian patients with schizophrenia in Singapore.
    Chua L, Chong SA, Pang E, Ng VP, Chan YH.
    Singapore Med J; 2001 Jun 30; 42(6):243-6. PubMed ID: 11547959
    [Abstract] [Full Text] [Related]

  • 28. Are cholinergic enhancers beneficial for memory in schizophrenia? An event-related potentials (ERPs) study of rivastigmine add-on therapy in a crossover trial.
    Guillem F, Chouinard S, Poulin J, Godbout R, Lalonde P, Melun P, Bentaleb LA, Stip E.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jul 30; 30(5):934-45. PubMed ID: 16580765
    [Abstract] [Full Text] [Related]

  • 29. Effects of donepezil adjunctive treatment to ziprasidone on cognitive deficits in schizophrenia: a double-blind, placebo-controlled study.
    Fagerlund B, Søholm B, Fink-Jensen A, Lublin H, Glenthøj BY.
    Clin Neuropharmacol; 2007 Jul 30; 30(1):3-12. PubMed ID: 17272964
    [Abstract] [Full Text] [Related]

  • 30. A meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia: opening a closed book.
    Mishara AL, Goldberg TE.
    Biol Psychiatry; 2004 May 15; 55(10):1013-22. PubMed ID: 15121486
    [Abstract] [Full Text] [Related]

  • 31. Exploring cognitive complaints in schizophrenia: the subjective scale to investigate cognition in schizophrenia.
    Stip E, Caron J, Renaud S, Pampoulova T, Lecomte Y.
    Compr Psychiatry; 2003 May 15; 44(4):331-40. PubMed ID: 12923712
    [Abstract] [Full Text] [Related]

  • 32. Treatment of cognitive dysfunction in chronic schizophrenia by augmentation of atypical antipsychotics with buspirone, a partial 5-HT(1A) receptor agonist.
    Piskulić D, Olver JS, Maruff P, Norman TR.
    Hum Psychopharmacol; 2009 Aug 15; 24(6):437-46. PubMed ID: 19637398
    [Abstract] [Full Text] [Related]

  • 33. [Cognitive remediation and cognitive assistive technologies in schizophrenia].
    Sablier J, Stip E, Franck N.
    Encephale; 2009 Apr 15; 35(2):160-7. PubMed ID: 19393385
    [Abstract] [Full Text] [Related]

  • 34. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA, Morrens M, Sabbe BG.
    Clin Ther; 2008 Sep 15; 30(9):1565-89. PubMed ID: 18840365
    [Abstract] [Full Text] [Related]

  • 35. A 12-week, double-blind, placebo-controlled trial of donepezil adjunctive treatment to risperidone in chronic and stable schizophrenia.
    Akhondzadeh S, Gerami M, Noroozian M, Karamghadiri N, Ghoreishi A, Abbasi SH, Rezazadeh SA.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec 12; 32(8):1810-5. PubMed ID: 18727948
    [Abstract] [Full Text] [Related]

  • 36. Neuropsychological impairment in deficit vs. non-deficit schizophrenia.
    Cascella NG, Testa SM, Meyer SM, Rao VA, Diaz-Asper CM, Pearlson GD, Schretlen DJ.
    J Psychiatr Res; 2008 Sep 12; 42(11):930-7. PubMed ID: 18021807
    [Abstract] [Full Text] [Related]

  • 37. Long-term stability of cognitive impairment in bipolar disorder: a 2-year follow-up study of lithium-treated euthymic bipolar patients.
    Mur M, Portella MJ, Martínez-Arán A, Pifarré J, Vieta E.
    J Clin Psychiatry; 2008 May 12; 69(5):712-9. PubMed ID: 18435565
    [Abstract] [Full Text] [Related]

  • 38. Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia.
    Olincy A, Harris JG, Johnson LL, Pender V, Kongs S, Allensworth D, Ellis J, Zerbe GO, Leonard S, Stevens KE, Stevens JO, Martin L, Adler LE, Soti F, Kem WR, Freedman R.
    Arch Gen Psychiatry; 2006 Jun 12; 63(6):630-8. PubMed ID: 16754836
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. IDEAL: a 6-month, double-blind, placebo-controlled study of the first skin patch for Alzheimer disease.
    Winblad B, Grossberg G, Frölich L, Farlow M, Zechner S, Nagel J, Lane R.
    Neurology; 2007 Jul 24; 69(4 Suppl 1):S14-22. PubMed ID: 17646619
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.